Literature DB >> 2357714

Chronic low-perfusion state in children with moyamoya disease following revascularization.

H Sato1, N Sato, N Tamaki, S Matsumoto.   

Abstract

The distribution pattern of cerebral blood flow (CBF) was evaluated in 13 children with moyamoya disease after revascularization. Combined surgery involving encephaloduroarteriosynangiosis and encephalomyosynangiosis was performed in 21 hemispheres. CBF was assessed by dynamic imaging using N-isopropylp[123I]iodoamphetamine-single photon emission CT (IMP-SPECT) at 46 months on average after revascularization. None of the patients suffered recurrent ischemic attacks after the bilateral combined surgery, and 62% showed excellent active daily life. However, 70% showed poor school performance with impaired cognitive function. Although the superficial temporal artery was dilated in follow-up angiograms, the revascularized area was confined to the craniotomy field. CBF images disclosed a low-perfusion state with a noninfarcted ischemic pattern in 71% of the revascularized hemispheres, especially in the frontal lobe. These findings show that although potentially beneficial effects can be expected following revascularization, it should be recognized that, in most patients, increased blood flow is gained only in a limited area around the surgical field. For patients who show progressive reduction of regional CBF, additional revascularization procedures are recommended.

Entities:  

Mesh:

Year:  1990        PMID: 2357714     DOI: 10.1007/bf00308495

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

1.  The Moyamoya syndrome and the neurosurgeon.

Authors:  H A Krayenbühl
Journal:  Surg Neurol       Date:  1975-10

2.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

3.  Incomplete cerebral infarction--focal incomplete ischemic tissue necrosis not leading to emollision.

Authors:  N A Lassen
Journal:  Stroke       Date:  1982 Jul-Aug       Impact factor: 7.914

4.  A surgical treatment of "moyamoya" disease "encephalo-myo synangiosis".

Authors:  J Karasawa; H Kikuchi; S Furuse; T Sakaki; Y Yoshida
Journal:  Neurol Med Chir (Tokyo)       Date:  1977       Impact factor: 1.742

5.  A new surgical treatment of moyamoya disease in children: a preliminary report.

Authors:  Y Matsushima; N Fukai; K Tanaka; S Tsuruoka; Y Inaba; M Aoyagi; K Ohno
Journal:  Surg Neurol       Date:  1981-04

6.  Alternative superficial temporal artery to middle cerebral artery revascularization procedure.

Authors:  R F Spetzler; R A Roski; D R Kopaniky
Journal:  Neurosurgery       Date:  1980-11       Impact factor: 4.654

7.  Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis ("moyamoya" disease) in children.

Authors:  Y Fukuyama; R Umezu
Journal:  Brain Dev       Date:  1985       Impact factor: 1.961

8.  Clinical and radioisotopic follow-up study of 'Moyamoya'.

Authors:  Y Maki; Y Nakada; T Nose; Y Yoshii
Journal:  Childs Brain       Date:  1976

9.  Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

Authors:  H Creutzig; O Schober; P Gielow; R Friedrich; H Becker; H Dietz; H Hundeshagen
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  The surgical treatment of childhood moyamoya disease.

Authors:  M V Olds; R W Griebel; H J Hoffman; M Craven; S Chuang; H Schutz
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115

View more
  19 in total

1.  Localized 1H-MR spectroscopy in moyamoya disease before and after revascularization surgery.

Authors:  Soo Mee Lim; Hye-Young Choi; Jung Soo Suh; Jung Hee Lee; Keun Ho Lim; Dae Chul Suh; Ho Kyu Lee; Tae-Hwan Lim; Young Shin Ra
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

2.  Differential clinical outcomes following encephaloduroarteriosynangiosis in pediatric moyamoya disease presenting with epilepsy or ischemia.

Authors:  Jong-Il Choi; Sung-Kon Ha; Dong-Jun Lim; Sang-Dae Kim
Journal:  Childs Nerv Syst       Date:  2015-03-01       Impact factor: 1.475

Review 3.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

4.  Magnetic resonance angiography in moyamoya disease.

Authors:  P A Battistella; C Carollo; P A Pellegrino; S Soriani; P Scarpa
Journal:  Childs Nerv Syst       Date:  1995-06       Impact factor: 1.475

5.  The scintigraphic appearance of childhood moyamoya disease on cerebral perfusion imaging.

Authors:  J H Miller; A Khonsary; C Raffel
Journal:  Pediatr Radiol       Date:  1996-12

Review 6.  Moyamoya disease in childhood: a familial case report.

Authors:  S Soriani; P Scarpa; A Voghenzi; L De Carlo; R Cilio
Journal:  Childs Nerv Syst       Date:  1993-07       Impact factor: 1.475

7.  Selective neuropsychological impairments and related clinical factors in children with moyamoya disease of the transient ischemic attack type.

Authors:  Yen-Hsuan Hsu; Meng-Fai Kuo; Mau-Sun Hua; Chi-Cheng Yang
Journal:  Childs Nerv Syst       Date:  2013-09-05       Impact factor: 1.475

8.  Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease.

Authors:  M A Mogensen; P Karzmark; P D Zeifert; J Rosenberg; M Marks; G K Steinberg; L J Dorfman
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

9.  Regional cerebral hemodynamics in childhood moyamoya disease.

Authors:  S Kuroda; K Houkin; H Kamiyama; H Abe; K Mitsumori
Journal:  Childs Nerv Syst       Date:  1995-10       Impact factor: 1.475

10.  Determinants of intellectual outcome after surgical revascularization in pediatric moyamoya disease: a multivariate analysis.

Authors:  Satoshi Kuroda; Kiyohiro Houkin; Tatsuya Ishikawa; Naoki Nakayama; Jun Ikeda; Nobuaki Ishii; Hiroyasu Kamiyama; Yoshinobu Iwasaki
Journal:  Childs Nerv Syst       Date:  2004-03-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.